Literature DB >> 31352232

Circulating follicular T helper cells are possibly associated with low levels of serum immunoglobulin G due to impaired immunoglobulin class-switch recombination of B cells in children with primary nephrotic syndrome.

Xia Yang1, Xiaoxiao Tang1, Ting Li1, Changming Man1, Xuejun Yang1, Mo Wang2, Gaofu Zhang2, Yaxi Chen3, Haiping Yang4, Qiu Li5.   

Abstract

Clinically, most patients with primary nephrotic syndrome (PNS) have low serum IgG levels, which is an important factor in infection and in PNS relapse.To some extent, the mechanisms involved remain largely unknown. Here, we aimed to investigate the pathogenesis of the decreased IgG levels in PNS. Peripheral blood was collected from patients with PNS and closely age- and sex-matched healthy individuals. The frequency, phenotype and molecular function of different circulating B cell and T follicular helper cell (TFH) subsets were examined by flow cytometry. The function of the CD40/CD40 L interaction in immunoglobulin class-switch recombination (CSR) was evaluated by assessing the induction of activation-induced deaminase (AID) expression with CD40 L stimulation. We revealed an increase in the levels of circulating total plasmablasts, plasma cells and mature-naive B cells and a decrease in the levels of germinal centre-like B cells and CD19+IgG+ B cells in PNS. In addition, although the expression of CD86 on the surface of B cells and the expression of the inducible costimulator (ICOS) on the surface of TFH cells both were increased, the expression of CD40 L on the surface of TFH cells was decreased. Moreover, upon stimulation with CD40 L in vitro, the mRNA expression of AID in peripheral blood mononuclear cells (PBMCs) was decreased in patients with PNS compared with that in healthy controls. Our results indicate that the immunoglobulin CSR of B cells was partly dysfunctional and provide insights into the potential involvement of impaired TFH cell-dependent B cell responses in the pathogenesis of low IgG levels through downregulating CD40 L expression on TFH cells in PNS.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  CD40 ligand; Class-Switch recombination; Follicular helper T cells; Low IgG; Primary nephrotic syndrome

Year:  2019        PMID: 31352232     DOI: 10.1016/j.molimm.2019.07.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Infections and risk of end-stage renal disease in patients with nephrotic syndrome: a nationwide population-based case-control study.

Authors:  Chien-Hung Lin; Peir-Haur Hung; Wen-Sheng Liu; Hsiao-Yun Hu; Chi-Jung Chung; Tsung-Hsien Chen
Journal:  Ann Transl Med       Date:  2020-03

Review 2.  B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover.

Authors:  Manuela Colucci; Julie Oniszczuk; Marina Vivarelli; Vincent Audard
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

3.  Association between HLA alleles and sub-phenotype of childhood steroid-sensitive nephrotic syndrome.

Authors:  Hao Lee; Li Wang; Fen-Fen Ni; Xue-Ying Yang; Shi-Pin Feng; Xiao-Jie Gao; Huan Chi; Ye-Tao Luo; Xue-Lan Chen; Bao-Hui Yang; Jun-Li Wan; Jia Jiao; Dao-Qi Wu; Gao-Fu Zhang; Mo Wang; Hai-Ping Yang; Han Chan; Qiu Li
Journal:  World J Pediatr       Date:  2022-01-01       Impact factor: 2.764

4.  Establishment of relapse risk model and multivariate logistic regression analysis on risk factors of relapse in children with primary nephrotic syndrome.

Authors:  Qian-Qian Peng; Ping Zeng; Xiao-Hua Jiang; Feng-Jun Guan
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

5.  Immunoglobulins concentration and B cell counts as severity markers in adult community-acquired pneumonia: Cross sectional study.

Authors:  Vivian Luchsinger; Luis Lizama; María Luisa Garmendia; Fabián Tempio; Mauricio Ruiz; Rolando Pizarro; Patricio Rossi; Lucía Huenchur; Cristian Moreno; Mercedes López; Sandra Ampuero; Carmen Larrañaga; Luis Fidel Avendaño
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.